Quick Answer
BIOCRYST PHARMACEUTICALS INC reported Total Assets of $514.16 million for fiscal year 2025.
BIOCRYST PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $514.16M | +4.8% |
| 2024 | $490.42M | -5.1% |
| 2023 | $516.96M | -6.0% |
| 2022 | $550.00M | -6.5% |
| 2021 | $588.15M | +75.7% |
| 2020 | $334.71M | +91.0% |
| 2019 | $175.28M | +19.4% |
| 2018 | $146.84M | -17.6% |
| 2017 | $178.26M | +98.4% |
| 2016 | $89.85M | -26.6% |
| 2015 | $122.36M | -10.6% |
| 2014 | $136.87M | +180.1% |
| 2013 | $48.87M | -14.9% |
| 2012 | $57.44M | -30.1% |
| 2011 | $82.21M | -24.9% |
| 2010 | $109.45M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $446.42M | -9.1% | -2.4% |
| June 30, 2025 | $457.19M | -3.2% | -4.8% |
| March 31, 2025 | $480.05M | +2.6% | -2.1% |
| December 31, 2024 | $490.42M | -5.1% | -0.2% |
| September 30, 2024 | $491.25M | -6.1% | +4.0% |
| June 30, 2024 | $472.42M | -10.8% | +1.0% |
| March 31, 2024 | $467.89M | -8.2% | -9.5% |
| December 31, 2023 | $516.96M | -6.0% | -1.1% |
- BIOCRYST PHARMACEUTICALS INC showed an increase of +4.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, BIOCRYST PHARMACEUTICALS INC’s total assets has grown by 369.8% (from $109.45 million to $514.16 million).
- The most recent figure is from BIOCRYST PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: